Induced pluripotent stem cells: developmental biology to regenerative medicine

Nuclear reprogramming of somatic cells with ectopic stemness factors to bioengineer pluripotent autologous stem cells signals a new era in regenerative medicine. The study of developmental biology has provided a roadmap for cardiac differentiation from embryonic tissue formation to adult heart muscle rejuvenation. Understanding the molecular mechanisms of stem-cell-derived cardiogenesis enables the reproducible generation, isolation, and monitoring of progenitors that have the capacity to recapitulate embryogenesis and differentiate into mature cardiac tissue. With the advent of induced pluripotent stem (iPS) cell technology, patient-specific stem cells provide a reference point to systematically decipher cardiogenic differentiation through discrete stages of development. Interrogation of iPS cells and their progeny from selected cohorts of patients is an innovative approach towards uncovering the molecular mechanisms of disease. Thus, the principles of cardiogenesis can now be applied to regenerative medicine in order to optimize personalized therapeutics, diagnostics, and discovery-based science for the development of novel clinical applications.

[1]  K. Parker,et al.  Cardiogenesis and the Complex Biology of Regenerative Cardiovascular Medicine , 2008, Science.

[2]  Benoit G. Bruneau,et al.  Directed transdifferentiation of mouse mesoderm to heart tissue by defined factors , 2009, Nature.

[3]  LimorZwi,et al.  Cardiomyocyte Differentiation of Human Induced Pluripotent Stem Cells , 2009 .

[4]  S. Rivkees,et al.  Neuregulin-1 promotes formation of the murine cardiac conduction system , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[5]  Hynek Wichterle,et al.  Induced Pluripotent Stem Cells Generated from Patients with ALS Can Be Differentiated into Motor Neurons , 2008, Science.

[6]  Deepak M. Gupta,et al.  Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells , 2009, Proceedings of the National Academy of Sciences.

[7]  Shinya Yamanaka,et al.  Pluripotency and nuclear reprogramming , 2008, Philosophical Transactions of the Royal Society B: Biological Sciences.

[8]  Wenjun Guo,et al.  Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds , 2008, Nature Biotechnology.

[9]  D. Clegg,et al.  Derivation of Functional Retinal Pigmented Epithelium from Induced Pluripotent Stem Cells , 2009, Stem cells.

[10]  Yi Zhang,et al.  Generation of Insulin-secreting Islet-like Clusters from Human Skin Fibroblasts*♦ , 2008, Journal of Biological Chemistry.

[11]  George Q. Daley,et al.  Disease-Specific Induced Pluripotent Stem Cells , 2008, Cell.

[12]  Timothy J. Nelson,et al.  Cardiogenic Induction of Pluripotent Stem Cells Streamlined Through a Conserved SDF-1/VEGF/BMP2 Integrated Network , 2010, PloS one.

[13]  Jeroen S. van Zon,et al.  Direct cell reprogramming is a stochastic process amenable to acceleration , 2009, Nature.

[14]  Anne Lindgren,et al.  Directed Differentiation of Human‐Induced Pluripotent Stem Cells Generates Active Motor Neurons , 2009, Stem cells.

[15]  A. Terzic,et al.  KCNJ11 knockout morula re-engineered by stem cell diploid aggregation , 2009, Philosophical Transactions of the Royal Society B: Biological Sciences.

[16]  Karl-Ludwig Laugwitz,et al.  Patient-specific induced pluripotent stem-cell models for long-QT syndrome. , 2010, The New England journal of medicine.

[17]  A. Terzic,et al.  Stem Cells: Biologics for Regeneration , 2008, Clinical pharmacology and therapeutics.

[18]  Yusuke Matsunaga,et al.  Characterization of Dendritic Cells and Macrophages Generated by Directed Differentiation from Mouse Induced Pluripotent Stem Cells , 2009, Stem cells.

[19]  T. Schoeb,et al.  Polycistronic Lentiviral Vector for “Hit and Run” Reprogramming of Adult Skin Fibroblasts to Induced Pluripotent Stem Cells , 2009, Stem cells.

[20]  Austin G Smith,et al.  Capturing Pluripotency , 2008, Cell.

[21]  Paul H Lerou,et al.  Generation of human-induced pluripotent stem cells , 2008, Nature Protocols.

[22]  Chad A. Cowan,et al.  A purified population of multipotent cardiovascular progenitors derived from primate pluripotent stem cells engrafts in postmyocardial infarcted nonhuman primates. , 2010, The Journal of clinical investigation.

[23]  L. Fink,et al.  Phenotypic correction of murine hemophilia A using an iPS cell-based therapy , 2009, Proceedings of the National Academy of Sciences.

[24]  R. Young,et al.  Stem Cells, the Molecular Circuitry of Pluripotency and Nuclear Reprogramming , 2008, Cell.

[25]  W. MacLellan,et al.  Genetic dissection of cardiac growth control pathways. , 2000, Annual review of physiology.

[26]  Gordon Keller,et al.  Differentiation of Embryonic Stem Cells to Clinically Relevant Populations: Lessons from Embryonic Development , 2008, Cell.

[27]  Stephen Dalton,et al.  Highly efficient generation of human hepatocyte–like cells from induced pluripotent stem cells , 2010, Hepatology.

[28]  Timothy J. Nelson,et al.  c-MYC-Independent Nuclear Reprogramming Favors Cardiogenic Potential of Induced Pluripotent Stem Cells , 2010, Journal of cardiovascular translational research.

[29]  I. Wilmut,et al.  Sheep cloned by nuclear transfer from a cultured cell line , 1996, Nature.

[30]  J. Alper.  Geron gets green light for human trial of ES cell–derived product , 2009, Nature Biotechnology.

[31]  R. Marcus,et al.  Diagnosis of post‐transplant lymphoproliferative disorder in solid organ transplant recipients – BCSH and BTS Guidelines , 2010, British journal of haematology.

[32]  B. Fleischmann,et al.  Developmental changes in contractility and sarcomeric proteins from the early embryonic to the adult stage in the mouse heart , 2003, The Journal of physiology.

[33]  A. Nagy,et al.  Production of mouse chimeras by aggregating pluripotent stem cells with embryos. , 2010, Methods in enzymology.

[34]  Shulan Tian,et al.  Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells , 2007, Science.

[35]  A. Terzic,et al.  Strategies for Therapeutic Repair: The “R3” Regenerative Medicine Paradigm , 2008, Clinical and translational science.

[36]  Zachary D. Smith,et al.  Dynamic single-cell imaging of direct reprogramming reveals an early specifying event , 2010, Nature Biotechnology.

[37]  R. Stewart,et al.  Human Induced Pluripotent Stem Cells Free of Vector and Transgene Sequences , 2009, Science.

[38]  Richard T. Lee,et al.  Cardiac Progenitor Cells and Biotinylated Insulin-Like Growth Factor-1 Nanofibers Improve Endogenous and Exogenous Myocardial Regeneration After Infarction , 2009, Circulation.

[39]  Austin G Smith,et al.  Mouse and human induced pluripotent stem cells as a source for multipotent Isl1+ cardiovascular progenitors , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[40]  Hideki Uosaki,et al.  Directed and Systematic Differentiation of Cardiovascular Cells From Mouse Induced Pluripotent Stem Cells , 2008, Circulation.

[41]  Wei Wang,et al.  piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells , 2009, Nature.

[42]  Lars S. Maier,et al.  Generation of Functional Murine Cardiac Myocytes From Induced Pluripotent Stem Cells , 2008, Circulation.

[43]  F. Fernández‐Avilés,et al.  Delivery of Biologics in Cardiovascular Regenerative Medicine , 2009, Clinical pharmacology and therapeutics.

[44]  J. Cibelli,et al.  Interspecies nuclear transfer: implications for embryonic stem cell biology. , 2007, Cell stem cell.

[45]  K. Woltjen,et al.  Virus free induction of pluripotency and subsequent excision of reprogramming factors , 2009, Nature.

[46]  J. Utikal,et al.  Immortalization eliminates a roadblock during cellular reprogramming into iPS cells , 2009, Nature.

[47]  Gu Weijun,et al.  Strategies and new developments in the generation of pluripotent stem cells. , 2009 .

[48]  G. Daley,et al.  Targeted bisulfite sequencing reveals changes in DNA methylation associated with nuclear reprogramming , 2009, Nature Biotechnology.

[49]  Robert Lanza,et al.  Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. , 2009, Cell stem cell.

[50]  H. Blau,et al.  Nuclear reprogramming to a pluripotent state by three approaches , 2010, Nature.

[51]  A. Terzic,et al.  Repair of Acute Myocardial Infarction With Induced Pluripotent Stem Cells Induced by Human Stemness Factors , 2009 .

[52]  D. Kraitchman,et al.  Current Perspectives on Imaging Cardiac Stem Cell Therapy , 2010, Journal of Nuclear Medicine.

[53]  Su-Chun Zhang,et al.  Modeling early retinal development with human embryonic and induced pluripotent stem cells , 2009, Proceedings of the National Academy of Sciences.

[54]  S. Yamanaka,et al.  The effects of cardioactive drugs on cardiomyocytes derived from human induced pluripotent stem cells. , 2009, Biochemical and biophysical research communications.

[55]  A. Terzic,et al.  Regenerative medicine advancing health care 2020. , 2010, Journal of the American College of Cardiology.

[56]  J. Shendure,et al.  A Molecular Pathway Including Id2, Tbx5, and Nkx2-5 Required for Cardiac Conduction System Development , 2007, Cell.

[57]  T. Mikkelsen,et al.  Dissecting direct reprogramming through integrative genomic analysis , 2008, Nature.

[58]  A. Consiglio,et al.  Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells , 2009, Nature.

[59]  H. Mizuguchi,et al.  Efficient Adipocyte and Osteoblast Differentiation from Mouse Induced Pluripotent Stem Cells by Adenoviral Transduction , 2009, Stem cells.

[60]  R. Jaenisch,et al.  Functional characterization of cardiomyocytes derived from murine induced pluripotent stem cells in vitro , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[61]  Manuel Serrano,et al.  A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity , 2009, Nature.

[62]  A. Kispert,et al.  Tbx18 and the fate of epicardial progenitors , 2009, Nature.

[63]  E. Olson.  The Path to the Heart and the Road Not Taken , 2001, Science.

[64]  Sheng Ding,et al.  A chemical platform for improved induction of human iPSCs , 2009, Nature Methods.

[65]  Robin Goland,et al.  Generation of pluripotent stem cells from patients with type 1 diabetes , 2009, Proceedings of the National Academy of Sciences.

[66]  R. Jaenisch,et al.  Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease , 2008, Proceedings of the National Academy of Sciences.

[67]  D. K. Arrell,et al.  Guided stem cell cardiopoiesis: discovery and translation. , 2008, Journal of molecular and cellular cardiology.

[68]  Y. Sasai,et al.  In vitro differentiation of retinal cells from human pluripotent stem cells by small-molecule induction , 2009, Journal of Cell Science.

[69]  Timothy J. Nelson,et al.  CXCR4+/FLK‐1+ Biomarkers Select a Cardiopoietic Lineage from Embryonic Stem Cells , 2008, Stem cells.

[70]  Marius Wernig,et al.  Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells , 2007, Nature Biotechnology.

[71]  Qi Zhou,et al.  iPS cells produce viable mice through tetraploid complementation , 2009, Nature.

[72]  Timothy J. Nelson,et al.  iPS Programmed Without c-MYC Yield Proficient Cardiogenesis for Functional Heart Chimerism , 2009, Circulation research.

[73]  P. Brundin,et al.  Critical issues of clinical human embryonic stem cell therapy for brain repair , 2008, Trends in Neurosciences.

[74]  S. Yamanaka,et al.  Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.

[75]  Shinya Yamanaka,et al.  Generation of Mouse Induced Pluripotent Stem Cells Without Viral Vectors , 2008, Science.

[76]  C. Dang,et al.  Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders. , 2009, Blood.

[77]  L. V. Van Laake,et al.  Reporter-Based Isolation of Induced Pluripotent Stem Cell– and Embryonic Stem Cell–Derived Cardiac Progenitors Reveals Limited Gene Expression Variance , 2010, Circulation research.

[78]  Shinya Yamanaka,et al.  Elite and stochastic models for induced pluripotent stem cell generation , 2009, Nature.

[79]  S. Yamanaka,et al.  Recent Stem Cell Advances: Induced Pluripotent Stem Cells for Disease Modeling and Stem Cell–Based Regeneration , 2010, Circulation.

[80]  Takahiro Ishiwata,et al.  Developmental Changes in Ventricular Diastolic Function Correlate With Changes in Ventricular Myoarchitecture in Normal Mouse Embryos , 2003, Circulation research.

[81]  M. Bönstrup,et al.  Development of a Drug Screening Platform Based on Engineered Heart Tissue , 2010, Circulation research.

[82]  Dong Wook Han,et al.  Generation of induced pluripotent stem cells using recombinant proteins. , 2009, Cell stem cell.

[83]  M. Blasco,et al.  The Ink4/Arf locus is a barrier for iPS cell reprogramming , 2009, Nature.

[84]  J. Slack,et al.  Origin of Stem Cells in Organogenesis , 2008, Science.

[85]  A. Consiglio,et al.  Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes , 2008, Nature Biotechnology.

[86]  E. Olson,et al.  A Common Progenitor at the Heart of Development , 2006, Cell.

[87]  Rene Spijker,et al.  Differentiation of Human Embryonic Stem Cells to Cardiomyocytes: Role of Coculture With Visceral Endoderm-Like Cells , 2003, Circulation.

[88]  Wei Jiang,et al.  Highly efficient differentiation of human ES cells and iPS cells into mature pancreatic insulin-producing cells , 2009, Cell Research.

[89]  M. Mercola,et al.  Wnt antagonism initiates cardiogenesis in Xenopus laevis. , 2001, Genes & development.

[90]  M. Blasco,et al.  Telomeres acquire embryonic stem cell characteristics in induced pluripotent stem cells. , 2009, Cell stem cell.

[91]  James A. Thomson,et al.  Induced pluripotent stem cells from a spinal muscular atrophy patient , 2009, Nature.

[92]  E. Olson.  A decade of discoveries in cardiac biology , 2004, Nature Medicine.

[93]  G. Stein,et al.  Pluripotency: Toward a gold standard for human ES and iPS cells , 2009, Journal of cellular physiology.

[94]  A. Viale,et al.  Modeling Pathogenesis and Treatment of Familial Dysautonomia using Patient Specific iPSCs , 2009, Nature.

[95]  K. Hochedlinger,et al.  Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells , 2009, Nature Genetics.

[96]  T. Ichisaka,et al.  Suppression of induced pluripotent stem cell generation by the p53–p21 pathway , 2009, Nature.

[97]  A. Lassar,et al.  Inhibition of Wnt activity induces heart formation from posterior mesoderm. , 2001, Genes & development.

[98]  Elina Minami,et al.  Cardiogenic Differentiation and Transdifferentiation of Progenitor Cells , 2008, Circulation research.

[99]  W. Sanger,et al.  Producing primate embryonic stem cells by somatic cell nuclear transfer , 2007, Nature.

[100]  Masaki Ieda,et al.  Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. , 2010, Cell.

[101]  G. Wahl,et al.  Linking the p53 tumor suppressor pathway to somatic cell reprogramming , 2009, Nature.

[102]  Sean P. Palecek,et al.  Functional Cardiomyocytes Derived From Human Induced Pluripotent Stem Cells , 2009, Circulation research.

[103]  Ge Guo,et al.  Nanog Is the Gateway to the Pluripotent Ground State , 2009, Cell.

[104]  T. Ichisaka,et al.  Hypoxia enhances the generation of induced pluripotent stem cells. , 2009, Cell stem cell.

[105]  Marius Wernig,et al.  Cardiac Myocytes Derived from Murine Reprogrammed Fibroblasts: Intact Hormonal Regulation, Cardiac Ion Channel Expression and Development of Contractility , 2009, Cellular Physiology and Biochemistry.

[106]  K. Plath,et al.  Reprogrammed Mouse Fibroblasts Differentiate into Cells of the Cardiovascular and Hematopoietic Lineages , 2008, Stem cells.

[107]  D. K. Arrell,et al.  Cardiopoietic programming of embryonic stem cells for tumor-free heart repair , 2007, The Journal of experimental medicine.

[108]  J. Utikal,et al.  Induced Pluripotent Stem Cells Generated Without Viral Integration , 2008, Science.

[109]  S. Yamanaka,et al.  Orderly hematopoietic development of induced pluripotent stem cells via Flk‐1+ hemoangiogenic progenitors , 2009, Journal of cellular physiology.

[110]  Tomohiro Kono,et al.  Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells , 2010, Nature.

[111]  Andre Terzic,et al.  Stem Cell Platforms for Regenerative Medicine , 2009, Clinical and translational science.

[112]  Marius Wernig,et al.  Treatment of Sickle Cell Anemia Mouse Model with iPS Cells Generated from Autologous Skin , 2007, Science.

[113]  F. D. de Gruijl,et al.  Molecular and Immunologic Mechanisms of Cancer Pathogenesis in Solid Organ Transplant Recipients , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[114]  B. Thiers.  Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2008 .

[115]  S. H. Wood,et al.  Development of Human Cloned Blastocysts Following Somatic Cell Nuclear Transfer with Adult Fibroblasts , 2008, Stem cells.

[116]  L. Fink,et al.  Generation and characterization of functional cardiomyocytes using induced pluripotent stem cells derived from human fibroblasts , 2009, Cell biology international.

[117]  C. Murry,et al.  Regenerating the heart , 2005, Nature Biotechnology.

[118]  Michael T. McManus,et al.  Dysregulation of Cardiogenesis, Cardiac Conduction, and Cell Cycle in Mice Lacking miRNA-1-2 , 2007, Cell.

[119]  Lei Yang,et al.  Patient-specific induced pluripotent stem cell derived models of LEOPARD syndrome , 2010, Nature.

[120]  W. Giles,et al.  Nkx2-5 Pathways and Congenital Heart Disease Loss of Ventricular Myocyte Lineage Specification Leads to Progressive Cardiomyopathy and Complete Heart Block , 2004, Cell.

[121]  Shinya Yamanaka,et al.  A Fresh Look at iPS Cells , 2009, Cell.

[122]  Bin Zhou,et al.  Epicardial progenitors contribute to the cardiomyocyte lineage in the developing heart , 2008, Nature.

[123]  C. Mummery,et al.  Origins and Fates of Cardiovascular Progenitor Cells , 2008, Cell.

[124]  J. Ellis,et al.  Retroviral vector silencing during iPS cell induction: An epigenetic beacon that signals distinct pluripotent states , 2008, Journal of cellular biochemistry.

[125]  벤자민 프라이어,et al.  Differentiation of human embryonic stem cells , 2011 .

[126]  Xiaolei Yin,et al.  Efficient generation of hepatocyte-like cells from human induced pluripotent stem cells , 2009, Cell Research.

[127]  Eric D. Adler,et al.  Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population , 2008, Nature.

[128]  C. Pereira,et al.  Senescence impairs successful reprogramming to pluripotent stem cells. , 2009, Genes & development.

[129]  W. Frishman,et al.  Cytokines and Myocardial Regeneration: A Novel Treatment Option for Acute Myocardial Infarction , 2009, Cardiology in review.

[130]  S. Kattman,et al.  Multipotent flk-1+ cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages. , 2006, Developmental cell.

[131]  A. Mares,et al.  HIT AND RUN , 1999 .

[132]  S. Yamanaka,et al.  Induction of pluripotent stem cells from fibroblast cultures , 2007, Nature Protocols.